MarketInOut Stock Screener Log In | Sign Up

Generate Biomedicines Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Generate Biomedicines Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,855.98 mln
Float55.21 mln
Earnings Date11/05/2026

Relative Strength

97 / 100
Top performer

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-952%
Severely loss-making

ROE

-26.51
Deeply negative

Altman Z-Score

9.3
Exceptional

ROA

-21.68
Deeply negative

Business Description

Generate Biomedicines is a biotechnology company based in Somerville, Massachusetts, that uses machine learning to design and develop new protein-based medicines. The company is advancing several drug candidates, including treatments targeting severe asthma, cancer, and other serious conditions. Its proprietary platform combines advanced computing with laboratory technology to create therapies that would be difficult or impossible to develop using conventional methods. Founded in 2018, the company aims to push the boundaries of what modern medicine can achieve.

Key Fundamentals

EPS-2.44
ROE-26.51
RPS0.32
ROIC-106
ROA-21.68
Interest Cover-304
EBITDA, mln-122
EV / EBITDA-10.66
EV / EBIT-10.12
Revenue, mln13.54
EV / Revenue96.08

Quote Details

Last 14.46
Change -1.31 (-8.31%)
Open 14.86
Volume 1,168,374
Turnover 16,894,688
Average Volume 1,067,936

Financial Ratios

Pre-Tax Profit Margin-952
Leverage Ratio1.23
Current Ratio8.30
Price / Book3.71
Price / Tangible Book3.71
Debt / Equity0.14
Price / Sales126

Financial Strength

Altman Z-Score9.3
Short Ratio7.37
Short % of Float11.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 16.52% 97 / 100   
1 Month 4.78% 84 / 100   
2 Months 5.7% 84 / 100   
6 Months 9.96% 83 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog